Back
Brookfield Asset Management Vs. Mirum Pharmaceuticals Industry Stock Comparison
Buy
69
BAM
Brookfield Asset Management
Last Price:
47.71
Seasonality Move:
5.35%
Sell
40
MIRM
Mirum Pharmaceuticals
Last Price:
39.35
Seasonality Move:
5.99%
Buy
69
Brookfield Asset Management (BAM)
is a Buy
Is Brookfield Asset Management a Buy, Sell or Hold?
- The current Brookfield Asset Management [BAM] share price is $47.70. The Score for BAM is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- BAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy, Sell or Hold?
- The current Mirum Pharmaceuticals [MIRM] share price is $37.93. The Score for MIRM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- MIRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BAM Stock Price Chart
What is Brookfield Asset Management's stock price today?
-
The Brookfield Asset Management share price today is $47.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
MIRM Stock Price Chart
What is Mirum Pharmaceuticals's stock price today?
-
The Mirum Pharmaceuticals share price today is $37.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight buying pressure.
BAM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.47 | Buy |
Relative Strength Index (14 RSI): | 79.96 | Buy |
Chaikin Money Flow: | 1070708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.14 - 44.4) | Buy |
Bollinger Bands (100): | (38.29 - 42.29) | Buy |
MIRM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 36.81 | Sell |
Chaikin Money Flow: | -512602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
BAM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.09 | Buy |
20-day SMA: | 42.71 | Buy |
50-day SMA: | 41.67 | Buy |
200-day SMA: | 40.08 | Buy |
8-day EMA: | 45.15 | Buy |
20-day EMA: | 43.38 | Buy |
50-day EMA: | 41.83 | Buy |
200-day EMA: | 39.44 | Buy |
MIRM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.68 | Sell |
20-day SMA: | 41.55 | Sell |
50-day SMA: | 40.65 | Sell |
200-day SMA: | 31.03 | Buy |
8-day EMA: | 40.34 | Sell |
20-day EMA: | 40.95 | Sell |
50-day EMA: | 39.41 | Sell |
200-day EMA: | 32.8 | Buy |
Brookfield Asset Management Earnings Growth & BAM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.07 per share, an increase this year of $0.05 per share, and an increase next year of $0.26 per share.
Mirum Pharmaceuticals Earnings Growth & MIRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.30 per share, an increase this year of $1.79 per share, and an increase next year of $0.88 per share.
Brookfield Asset Management Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Mirum Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |